Engineered Receptors Help the Immune System Home in on Cancer
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer therapies with minimal side effects.
University of California San Francisco
Give to UCSFUCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer therapies with minimal side effects.
An AI-based diagnostic system reveals cancerous tissue that may not otherwise be visible during brain tumor surgery. This enables neurosurgeons to remove it while the patient is still under anesthesia – or treat it afterwards with targeted therapies.
New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering
In June, UCSF treated its first patient with E-SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This story builds on previous coverage to provide an overview of CAR-T therapy, accessibility and future horizons of applications in cancer and other illnesses like HIV.
Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology (JCO GO), an American Society of Clinical Oncology (ASCO) journal.
Men could have fewer unnecessary treatments and reduced anxiety if doctors stopped calling certain changes in the prostate “cancer.”
UCSF hosted NASA astronauts and scientists in a daylong, invitational scientific roundtable in conjunction with the White House Cancer Moonshot Initiative. Astronauts also visited pediatric patients at UCSF Benioff Children’s Hospital San Francisco, and greeted event attendees.
UCSF Benioff Children’s Hospitals have tied as the best hospitals in Northern California in the 2024-2025 U.S. News & World Report Best Children’s Hospitals list.
With rising rates of colorectal cancers in younger people, UCSF experts tell you that getting screened for cancer may be as easy as getting a flu shot.
Breast cancer is the second leading cause of cancer deaths in the U.S. and worldwide, pointing to the continuing need to improve treatment strategies and therapies that better patient survival and
The UC Board of Regents approved UCSF’s proposal to build a proton therapy facility as part of the redevelopment of the former Dogpatch Power Station, which will join only 45 other sites nationwide and will be the only facility to offer the leading-edge cancer therapy between Los Angeles and Seattle.
Black men are more than twice as likely to die of prostate cancer than their white peers. An innovative community-based UCSF program is increasing screenings among San Francisco's Black communities.
Scientists discover how to drug GTPases, a group of 150 critical enzymes that act like "switches" in cells, which cause a wide variety of diseases such as cancer and Parkinson’s disease when mutated.
Mack Roach, III, MD, FASTRO, has been chosen by the American Society for Radiation Oncology (ASTRO) to receive its 2024 Gold Medal Award. Roach is being recognized with ASTRO’s highest honor for his
The UCSF Prostate Cancer Program will receive about $7 million from the National Cancer Institute to develop new approaches to the prevention, early detection, diagnosis and treatment of prostate cancer.
Mekhail Anwar leads a multi-institution $15 million grant from ARPA-H to develop imaging technology to improve cancer surgery.
A breakthrough study shows how a ketogenic diet alters human metabolism and makes a particular pancreatic cancer drug effective by starving tumors of fat that they feed on to grow.
Results from a national study led by UCSF informed the first guidelines at the federal level in the U.S. to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research,
Three UC San Francisco scientists have received 2024 Pew awards to fund their research in neuroscience and cancer: cognitive scientist Vijay Mohan K Namboodiri, PhD; bioengineer Justin Eyquem, PhD; and postodctoral student Jovanka Gencel-Augusto, PhD.
Our genome may one day serve as a passport guiding our health care – from cradle to grave.